New product launches, presence at trade fairs and congresses, scientific publications, strategic alliances, corporate developments... You’ll find all our news in this section. Don’t hesitate to get in touch with us if you require any further information.
Recent studies show that there is no standard response to Heparin treatment and that it must be adapted for each individual
There is a correlation between the response to Heparin and thrombin formation in each individual. Researchers have also observed that with greater thrombin production there is a greater risk of thrombosis
The goal is to acknowledge the best journalism articles and reports on heparin and to encourage the work of professionals who file stories on health, economics and the biotech industry in Spain
Heparin is the most widely used anticoagulant and antithrombotic drug in the world and is calculated to save more than 100 million lives every year